Firms
Theme

AXON

Axon Enterprise, Inc. · NASDAQ

News

13 latest

Zacks Investment Research

Why Axon Enterprise (AXON) Outpaced the Stock Market Today

Axon Enterprise (AXON) closed at $403.02, up 2.64%, outperforming the S&P 500. The company has a Zacks Rank #1 (Strong Buy) rating with expected EPS growth of 65.81% and revenue growth of 31.03% for the upcoming quarter. However, the stock trades at a premium valuation with a Forward P/E of 49.8 compared to its industry average of 30.85.

Zacks Investment Research

Axon Enterprise (AXON) Laps the Stock Market: Here's Why

Axon Enterprise (AXON) closed at $392.53, up 2.46%, outperforming the S&P 500's 0.28% gain. The company holds a Zacks Rank #1 (Strong Buy) rating with anticipated Q earnings of $1.94 EPS (+65.81% YoY) and revenue of $934.1M (+31.44% YoY). However, the stock trades at a premium Forward P/E of 48.59 versus the industry average of 31.25.

Zacks Investment Research

Here's Why Axon Enterprise (AXON) Fell More Than Broader Market

Axon Enterprise (AXON) declined 1.34% to $407.80, underperforming the S&P 500's 1.11% loss. The stock has dropped 6.5% over the past month.

Zacks Investment Research

Axon Enterprise, Inc (AXON) is Attracting Investor Attention: Here is What You Should Know

Axon Enterprise has attracted investor attention despite a -6.5% return over the past month. The company is expected to report strong earnings growth of +65.8% year-over-year for the current quarter and +15% for the fiscal year.

Zacks Investment Research

Axon (AXON) Upgraded to Strong Buy: Here's Why

Axon Enterprise (AXON) has been upgraded to Zacks Rank #1 (Strong Buy) following a 30.3% increase in consensus earnings estimates over the past three months. The upgrade reflects improving business fundamentals and positions the stock in the top 5% of Zacks-covered stocks, suggesting potential for near-term price appreciation driven by institutional investor buying based on revised earnings outlooks.

Zacks Investment Research

Axon Enterprise (AXON) Rises As Market Takes a Dip: Key Facts

Axon Enterprise (AXON) closed at $417.31, up 2.79% in the latest session, outperforming the S&P 500. The company is projected to report earnings of $1.94 per share with 65.81% year-over-year growth and quarterly revenue of $935.35 million, up 31.62%. AXON holds a Zacks Rank #2 (Buy) rating with a Forward P/E of 51.5, trading at a premium to its industry average.

Zacks Investment Research

Axon Enterprise (AXON) Stock Falls Amid Market Uptick: What Investors Need to Know

Axon Enterprise stock declined 2.1% to $413.35, underperforming the broader market despite positive analyst expectations. The company is projected to report earnings of $1.94 per share (65.81% YoY growth) and revenue of $935.35 million (31.62% growth).

Zacks Investment Research

Axon Enterprise, Inc (AXON) Is a Trending Stock: Facts to Know Before Betting on It

Axon Enterprise has been trending on Zacks.com's most searched stocks list. The stock has declined 19.1% over the past month, significantly underperforming the S&P 500. While the company shows strong revenue growth forecasts (+32.4% for current fiscal year) and positive earnings revisions, it carries a Zacks Rank #3 (Hold) rating and trades at a premium valuation with an F grade on value metrics, suggesting it may perform in line with the broader market in the near term.

Mentions AXON

The Motley Fool

Arista Networks vs. Axon Enterprise: Which Tech Stock Is a Better Buy in 2026?

The article compares two high-growth tech stocks: Arista Networks, a networking infrastructure provider for AI data centers with strong profitability but customer concentration risk, and Axon Enterprise, a public safety technology company with diverse customers and impressive software growth. Despite Arista's higher margins and lower P/E ratio, the author recommends Axon as the better buy in 2026, citing its more attractive PEG ratio of 1.36x versus Arista's 2x, following Axon's 50% stock decline from its 2025 peak.

The Motley Fool

Breakfast News: Stocks to Think About Selling

Motley Fool analysts from Team Rule Breakers and Team Hidden Gems identify five stocks worth considering selling: Zoom Communications for stagnant growth despite profitability, Block for slowing user growth and Bitcoin dependence, Cellebrite for limited expansion potential compared to competitors, and Workday for expected modest returns despite AI investments. The article emphasizes that selling decisions deserve as much rigor as buying decisions, and investors should reassess holdings when original investment theses no longer hold.

The Motley Fool

How Nvidia Could Make $150 Billion Look Small

Nvidia announced a $150 billion share repurchase program, its largest in history, but contributors argue it's insufficient for a $5 trillion company and suggest a $500 billion buyback would be more impressive. The announcement coincided with an AI safety initiative, potentially masking concerns about slowing growth, competitive threats from hyperscalers developing their own chips, and questions about whether existing GPU hardware may become adequate for most enterprise workloads, potentially slowing upgrade cycles.

The Motley Fool

Breakfast News: Stocks to Think About Selling

Motley Fool analysts from Team Rule Breakers and Team Hidden Gems identify five stocks worth considering selling: Zoom Communications for stagnant growth despite profitability, Block for slowing Cash App growth and Bitcoin reliance, Cellebrite for limited expansion potential compared to competitors, and Workday for expected modest 6-8% annual returns despite recent AI investments. The article emphasizes that selling decisions deserve as much rigor as buying decisions, and investors should reassess holdings when original investment theses no longer hold.

Zacks Investment Research

Can Axon Sustain EBITDA Margin Momentum Amid Cost Pressures?

Axon Enterprise reported strong Q2 2026 results with revenues surging 35.3% to $904.4 million and adjusted EBITDA margin expanding 110 basis points to 26.8%, despite escalating operating expenses. The company targets a 28% adjusted EBITDA margin by 2028 with $6 billion in annual revenues, driven by robust demand for products like TASER 10 and Axon Body 4, plus growing international expansion.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $AXON · 0 threads

Sign in to post on $AXON

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev